Kuriyama H - Search Results

1

Genetic determinants of malignancy in a mouse model for oligodendroglioma.

Weiss WA, Burns MJ, Hackett C, Aldape K, Hill JR, Kuriyama H, Kuriyama N, Milshteyn N, Roberts T, Wendland MF, DePinho R, Israel MA. Weiss WA, et al. Among authors: kuriyama h, kuriyama n. Cancer Res. 2003 Apr 1;63(7):1589-95. Cancer Res. 2003. PMID: 12670909

2

Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.

Kuriyama N, Kuriyama H, Julin CM, Lamborn KR, Israel MA. Kuriyama N, et al. Among authors: kuriyama h. Cancer Res. 2001 Mar 1;61(5):1805-9. Cancer Res. 2001. PMID: 11280727

3

Fas (APO-1/CD95) signaling pathway is intact in radioresistant human glioma cells.

Yount GL, Levine KS, Kuriyama H, Haas-Kogan DA, Israel MA. Yount GL, et al. Among authors: kuriyama h. Cancer Res. 1999 Mar 15;59(6):1362-5. Cancer Res. 1999. PMID: 10096571

4

Molecular genetics of brain tumors.

Hill JR, Kuriyama N, Kuriyama H, Israel MA. Hill JR, et al. Among authors: kuriyama h, kuriyama n. Arch Neurol. 1999 Apr;56(4):439-41. doi: 10.1001/archneur.56.4.439. Arch Neurol. 1999. PMID: 10199332 Review.

5

A head holder for magnetic resonance imaging that allows the stereotaxic alignment of spontaneously occurring intracranial mouse tumors.

Tada T, Wendland M, Watson N, Kuriyama N, Kuriyama H, Roberts T, Burns M, Weiss W, Israel MA. Tada T, et al. Among authors: kuriyama h, kuriyama n. J Neurosci Methods. 2002 Apr 30;116(1):1-7. doi: 10.1016/s0165-0270(02)00014-6. J Neurosci Methods. 2002. PMID: 12007978

6

Pretreatment with protease is a useful experimental strategy for enhancing adenovirus-mediated cancer gene therapy.

Kuriyama N, Kuriyama H, Julin CM, Lamborn K, Israel MA. Kuriyama N, et al. Among authors: kuriyama h. Hum Gene Ther. 2000 Nov 1;11(16):2219-30. doi: 10.1089/104303400750035744. Hum Gene Ther. 2000. PMID: 11084679

7

Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas.

Kuriyama H, Lamborn KR, O'Fallon JR, Iturria N, Sebo T, Schaefer PL, Scheithauer BW, Buckner JC, Kuriyama N, Jenkins RB, Israel MA. Kuriyama H, et al. Among authors: kuriyama n. Neuro Oncol. 2002 Jul;4(3):179-86. doi: 10.1093/neuonc/4.3.179. Neuro Oncol. 2002. PMID: 12084348 Free PMC article.

8

Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces.

Matsuoka Y, Kuroki M, Koga Y, Kuriyama H, Mori T, Kosaki G. Matsuoka Y, et al. Among authors: kuriyama h. Cancer Res. 1982 May;42(5):2012-8. Cancer Res. 1982. PMID: 6175402

9

[Antigenic structure of NCA-2 from meconium and comparison with normal fecal antigen from adult feces and carcinoembryonic antigen from malignant tissues].

Kuriyama H. Kuriyama H. Nihon Geka Gakkai Zasshi. 1983 Apr;84(4):301-9. Nihon Geka Gakkai Zasshi. 1983. PMID: 6201714 Japanese.

10

Metastasis to hypopharynx from epidermotropic metastatic malignant melanoma.

Mizuhashi S, Miyashita A, Kuriyama H, Kimura T, Kanemaru H, Miyamaru S, Saeki S, Fukushima S. Mizuhashi S, et al. Among authors: kuriyama h. Drug Discov Ther. 2024 Jun 6;18(2):140-142. doi: 10.5582/ddt.2024.01017. Epub 2024 Apr 17. Drug Discov Ther. 2024. PMID: 38631866 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

539 results

Search Page

Filters